Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01948297 |
| Title | Debio 1347-101 Phase I Trial in Advanced Solid Tumours With Fibroblast Growth Factor Receptor (FGFR) Alterations |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | Yes |
| Sponsors | Debiopharm International SA |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | ESP |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02114 | United States | Details | |
| Massachusetts General Hospital | Boston | Massachusetts | 02215 | United States | Details | |
| Memorial Sloan-Kettering Hospital | New York | New York | 10065 | United States | Details | |
| The University of Texas; MD Anderson Cancer Center | Houston | Texas | 77030-4009 | United States | Details | |
| Seoul National University Hospital | Seoul | 03080 | Korea, Republic of | Details | ||
| National Cancer Center Singapore | Singapore | 169610 | Singapore | Details | ||
| Vall d'Hebron University Hospital | Barcelona | Spain | Details | |||
| Taipei Medical University Hospital | Taipei | 11031 | Taiwan | Details |